CS logo
small CS logo
Instituto do Cancer do Estado de Sao Paulo - ICESP

Sao Paulo, SP, Brazil
Centro de tratamento de câncer em São Paulo

About Instituto do Cancer do Estado de Sao Paulo - ICESP


Instituto do Câncer de São Paulo Octavio Frias de Oliveira é um centro de atendimento médico e hospitalar que funciona como autarquia vinculada ao Governo do Estado de São Paulo.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Instituto do Cancer do Estado de São Paulo
39
Hoffmann-La Roche
37
Latin American Cooperative Oncology Group
8
EMD Serono Research & Development Institute, Inc.
7
University of Sao Paulo
7
Pfizer
6
Eli Lilly and Company
5
Bayer
3
Eurofarma Laboratorios S.A.
3
Genentech, Inc.
3
Agenus Inc.
2
Total Rows: 38

Clinical Trials at Instituto do Cancer do Estado de Sao Paulo - ICESP


During the past decade, Instituto do Cancer do Estado de Sao Paulo - ICESP conducted 99 clinical trials. In the 10-year time frame, 99 clinical trials started and 34 clinical trials were completed, i.e. on average, 34.3% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 13 clinical trials were completed. i.e. 38.2% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years141499161610101616181899772222557755445522Started TrialsCompleted Trails2015201620172018201920202021202201020
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
2008-02-12
2018-11-23
Completed
808
Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
2008-04-01
2015-04-01
Completed
791
A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen
2008-11-01
2014-08-01
Completed
188
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
2010-01-01
2015-12-01
Completed
1,069
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
2009-10-16
2017-01-24
Completed
596
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
2010-07-31
2016-09-16
Completed
1,095
A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung
2011-01-13
2016-11-30
Completed
343
Iron Supplement in the Prevention of Anemia in Female Breast Cancer Patients
2010-05-01
2014-12-01
Unknown status
100

Rows per page:

1–100 of 154

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Instituto do Cancer do Estado de Sao Paulo - ICESP" #1 sponsor was "Instituto do Cancer do Estado de São Paulo" with 39 trials, followed by "Hoffmann-La Roche" with 37 trials sponsored, "Latin American Cooperative Oncology Group" with 8 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 7 trials sponsored and "University of Sao Paulo" with 7 trials sponsored. Other sponsors include 51 different institutions and companies that sponsored additional 38 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto do Cancer do Estado de Sao Paulo - ICESP" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 8 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Fundação Faculdade de Medicina" with 3 trials as a collaborator and "Instituto do Cancer do Estado de São Paulo" with 3 trials as a collaborator. Other collaborators include 47 different institutions and companies that were collaborators in the rest 44 trials.
Created with Highcharts 11.1.0Top Leading SponsorsInstituto do Cancer doEstado de São Paulo: 39Instituto do Cancer doEstado de São Paulo: 39Hoffmann-La Roche: 37Hoffmann-La Roche: 37Latin AmericanCooperative OncologyGroup: 8Latin AmericanCooperative OncologyGroup: 8EMD Serono Research &Development Institute,Inc.: 7EMD Serono Research &Development Institute,Inc.: 7University of Sao Paulo: 7University of Sao Paulo: 7Pfizer: 6Pfizer: 6Eli Lilly and Company: 5Eli Lilly and Company: 5Bayer: 3Bayer: 3Eurofarma Laboratorios S.A.: 3Eurofarma Laboratorios S.A.: 3Genentech, Inc.: 3Genentech, Inc.: 3

Created with Highcharts 11.1.0Top CollaboratorsMerck KGaA,Darmstadt, Germany: 8Merck KGaA,Darmstadt, Germany: 8AstraZeneca: 3AstraZeneca: 3Eli Lilly and Company: 3Eli Lilly and Company: 3Fundação Faculdade deMedicina: 3Fundação Faculdade deMedicina: 3Instituto do Cancer doEstado de São Paulo: 3Instituto do Cancer doEstado de São Paulo: 3Merck Sharp & Dohme LLC: 3Merck Sharp & Dohme LLC: 3NSABP Foundation Inc: 3NSABP Foundation Inc: 3Pfizer: 3Pfizer: 3Astellas Pharma Inc: 2Astellas Pharma Inc: 2Fundação de Amparo àPesquisa do Estado deSão Paulo: 2Fundação de Amparo àPesquisa do Estado deSão Paulo: 2

Clinical Trials Conditions at Instituto do Cancer do Estado de Sao Paulo - ICESP


According to Clinical.Site data, the most researched conditions in "Instituto do Cancer do Estado de Sao Paulo - ICESP" are "Breast Cancer" (18 trials), "Non-Small Cell Lung Cancer" (6 trials), "Cancer" (5 trials), "Prostate Cancer" (5 trials) and "Cervical Cancer" (4 trials). Many other conditions were trialed in "Instituto do Cancer do Estado de Sao Paulo - ICESP" in a lesser frequency.

Clinical Trials Intervention Types at Instituto do Cancer do Estado de Sao Paulo - ICESP


Most popular intervention types in "Instituto do Cancer do Estado de Sao Paulo - ICESP" are "Drug" (118 trials), "Other" (15 trials), "Procedure" (12 trials), "Radiation" (12 trials) and "Device" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (20 trials), "Carboplatin" (14 trials), "Cisplatin" (14 trials), "Atezolizumab" (13 trials) and "Gemcitabine" (9 trials). Other intervention names were less common.

Clinical Trials Genders at Instituto do Cancer do Estado de Sao Paulo - ICESP


The vast majority of trials in "Instituto do Cancer do Estado de Sao Paulo - ICESP" are 119 trials for "All" genders, 21 trials for "Female" genders and 14 trials for "Male" genders.

Clinical Trials Status at Instituto do Cancer do Estado de Sao Paulo - ICESP


Currently, there are NaN active trials in "Instituto do Cancer do Estado de Sao Paulo - ICESP". 1 are not yet recruiting, 32 are recruiting, 35 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 57 completed trials in Instituto do Cancer do Estado de Sao Paulo - ICESP, undefined suspended trials, and 10 terminated clinical trials to date.
Out of the total trials that were conducted in Instituto do Cancer do Estado de Sao Paulo - ICESP, 2 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 18 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 69Phase 3: 69Phase 2: 54Phase 2: 54Not Applicable: 18Not Applicable: 18Phase 4: 4Phase 4: 4Phase 1: 2Phase 1: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 57Completed: 57Active, not recruiting: 35Active, not recruiting: 35Recruiting: 32Recruiting: 32Unknown status: 14Unknown status: 14Terminated: 10Terminated: 10Withdrawn: 4Withdrawn: 4Available: 1Available: 1Not yet recruiting: 1Not yet recruiting: 1

Departments of Instituto do Cancer do Estado de Sao Paulo - ICESP


Instituto do Cancer do Estado de Sao Paulo - ICESP has several departments that took part in Clinical trials: "Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa" - 2 trials, "Instituto do Câncer de São Paulo - ICESP" - 2 trials